We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Perficient Inc | NASDAQ:PRFT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.03% | 73.28 | 73.15 | 73.28 | 73.40 | 73.17 | 73.28 | 2,609,101 | 00:31:34 |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
No. 74-2853258
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
|
☑
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
|
Smaller reporting company
|
|
Emerging growth company
|
☐
|
|
|
|
Part I.
|
Financial Information
|
1
|
|
|
|
Item 1.
|
Financial Statements
|
2
|
|
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2017 (unaudited) and December 31, 2016
|
2
|
|
|
|
|
Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2017 and 2016
|
3
|
|
|
|
|
Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2017 and 2016
|
4
|
|
|
|
|
Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the Three Months Ended March 31, 2017
|
5
|
|
|
|
|
Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2017 and 2016
|
6
|
|
|
|
|
Notes to Interim Unaudited Condensed Consolidated Financial Statements
|
7
|
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
16
|
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
22
|
|
|
|
Item 4.
|
Controls and Procedures
|
22
|
|
|
|
Part II.
|
Other Information
|
23
|
|
|
|
Item 1A.
|
Risk Factors
|
23
|
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
23
|
|
|
|
Item 5.
|
Other Information
|
23
|
|
|
|
Item 6.
|
Exhibits
|
23
|
|
|
|
|
Signatures
|
24
|
(1) |
the impact of the general economy and economic uncertainty on our business;
|
(2) |
risks associated with uncertainties resulting from changes to policies and laws following the U.S. elections in November 2016;
|
(3) |
risks associated with the operation of our business generally, including:
|
(4) |
legal liabilities, including intellectual property protection and infringement or the disclosure of personally identifiable information;
|
(5) |
risks associated with managing growth organically and through acquisitions; and
|
(6) |
the risks detailed from time to time within our filings with the Securities and Exchange Commission (the “SEC”).
|
|
March 31, 2017
(unaudited)
|
December 31, 2016
|
||||||
ASSETS
|
(In thousands, except share and per share information)
|
|||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
10,887
|
$
|
10,113
|
||||
Accounts receivable, net
|
87,650
|
103,702
|
||||||
Prepaid expenses
|
4,721
|
3,353
|
||||||
Other current assets
|
5,924
|
5,331
|
||||||
Total current assets
|
109,182
|
122,499
|
||||||
Property and equipment, net
|
8,137
|
8,888
|
||||||
Goodwill
|
281,241
|
275,205
|
||||||
Intangible assets, net
|
46,764
|
45,115
|
||||||
Other non-current assets
|
5,210
|
4,869
|
||||||
Total assets
|
$
|
450,534
|
$
|
456,576
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
9,984
|
$
|
18,416
|
||||
Other current liabilities
|
22,956
|
27,637
|
||||||
Total current liabilities
|
32,940
|
46,053
|
||||||
Long-term debt
|
38,500
|
32,000
|
||||||
Other non-current liabilities
|
20,835
|
19,058
|
||||||
Total liabilities
|
$
|
92,275
|
$
|
97,111
|
||||
|
||||||||
Stockholders’ equity:
|
||||||||
Common stock (par value $0.001 per share; 50,000,000 shares authorized; 46,370,362 shares issued and 33,759,335 shares outstanding as of March 31, 2017; 45,895,086 shares issued and 33,865,688 shares outstanding as of December 31, 2016)
|
$
|
46
|
$
|
46
|
||||
Additional paid-in capital
|
385,280
|
379,094
|
||||||
Accumulated other comprehensive loss
|
(2,427
|
)
|
(2,743
|
)
|
||||
Treasury stock, at cost (12,611,027 shares as of March 31, 2017; 12,029,398 shares as of December 31, 2016)
|
(136,859
|
)
|
(126,442
|
)
|
||||
Retained earnings
|
112,219
|
109,510
|
||||||
Total stockholders’ equity
|
358,259
|
359,465
|
||||||
Total liabilities and stockholders’ equity
|
$
|
450,534
|
$
|
456,576
|
Three Months Ended
|
||||||||
|
March 31,
|
|||||||
|
2017
|
2016
|
||||||
|
(In thousands, except per share information)
|
|||||||
Revenues
|
||||||||
Services
|
$
|
100,888
|
$
|
109,747
|
||||
Software and hardware
|
6,998
|
9,476
|
||||||
Reimbursable expenses
|
3,133
|
4,620
|
||||||
Total revenues
|
111,019
|
123,843
|
||||||
Cost of revenues (exclusive of depreciation and amortization, shown separately below)
|
||||||||
Cost of services
|
65,846
|
71,587
|
||||||
Software and hardware costs
|
5,965
|
7,412
|
||||||
Reimbursable expenses
|
3,133
|
4,620
|
||||||
Total cost of revenues
|
74,944
|
83,619
|
||||||
|
||||||||
Gross margin
|
36,075
|
40,224
|
||||||
|
||||||||
Selling, general and administrative
|
25,684
|
26,714
|
||||||
Depreciation
|
1,259
|
1,192
|
||||||
Amortization
|
3,625
|
3,365
|
||||||
Acquisition costs
|
490
|
243
|
||||||
Adjustment to fair value of contingent consideration
|
158
|
238
|
||||||
Income from operations
|
4,859
|
8,472
|
||||||
|
||||||||
Net interest expense
|
347
|
520
|
||||||
Net other (income) expense
|
(18
|
)
|
103
|
|||||
Income before income taxes
|
4,530
|
7,849
|
||||||
Provision for income taxes
|
1,821
|
2,443
|
||||||
|
||||||||
Net income
|
$
|
2,709
|
$
|
5,406
|
||||
|
||||||||
Basic net income per share
|
$
|
0.08
|
$
|
0.16
|
||||
Diluted net income per share
|
$
|
0.08
|
$
|
0.16
|
||||
Shares used in computing basic net income per share
|
33,383
|
33,911
|
||||||
Shares used in computing diluted net income per share
|
34,294
|
34,842
|
|
Three Months Ended | |||||||
|
March 31,
|
|||||||
|
|
2017
|
2016
|
|||||
|
(In thousands)
|
|||||||
Net income
|
$
|
2,709
|
$
|
5,406
|
||||
Other comprehensive income:
|
||||||||
Foreign currency translation adjustment
|
316
|
192
|
||||||
Comprehensive income
|
$
|
3,025
|
$
|
5,598
|
|
Common Stock
Shares
|
Common Stock
Amount
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Treasury Stock
|
Retained Earnings
|
Total
Stockholders’ Equity
|
|||||||||||||||||||||
|
||||||||||||||||||||||||||||
Balance at December 31, 2016
|
33,866
|
$
|
46
|
$
|
379,094
|
$
|
(2,743
|
)
|
$
|
(126,442
|
)
|
$
|
109,510
|
$
|
359,465
|
|||||||||||||
Proceeds from the sales of stock through the Employee Stock Purchase Plan
|
3
|
--
|
47
|
--
|
--
|
--
|
47
|
|||||||||||||||||||||
Stock compensation related to restricted stock vesting and retirement savings plan contributions
|
326
|
--
|
3,589
|
--
|
--
|
--
|
3,589
|
|||||||||||||||||||||
Purchases of treasury stock and buyback of shares for taxes
|
(582
|
)
|
--
|
--
|
--
|
(10,417
|
)
|
--
|
(10,417
|
)
|
||||||||||||||||||
Issuance of stock for acquisitions
|
146
|
--
|
2,550
|
--
|
--
|
--
|
2,550
|
|||||||||||||||||||||
Net income
|
--
|
--
|
--
|
--
|
--
|
2,709
|
2,709
|
|||||||||||||||||||||
Foreign currency translation adjustment
|
--
|
--
|
--
|
316
|
--
|
--
|
316
|
|||||||||||||||||||||
Balance at March 31, 2017
|
33,759
|
$
|
46
|
$
|
385,280
|
$
|
(2,427
|
)
|
$
|
(136,859
|
)
|
$
|
112,219
|
$
|
358,259
|
Three Months Ended
|
||||||||
|
March 31,
|
|||||||
|
2017
|
2016
|
||||||
|
(In thousands)
|
|||||||
OPERATING ACTIVITIES
|
||||||||
Net income
|
$
|
2,709
|
$
|
5,406
|
||||
Adjustments to reconcile net income to net cash provided by operations:
|
||||||||
Depreciation
|
1,259
|
1,192
|
||||||
Amortization
|
3,625
|
3,365
|
||||||
Deferred income taxes
|
1,502
|
651
|
||||||
Non-cash stock compensation and retirement savings plan contributions
|
3,589
|
3,523
|
||||||
Adjustment to fair value of contingent consideration for purchase of business
|
158
|
238
|
||||||
|
||||||||
Changes in operating assets and liabilities, net of acquisitions:
|
||||||||
Accounts receivable
|
16,660
|
3,727
|
||||||
Other assets
|
(1,441
|
)
|
1,044
|
|||||
Accounts payable
|
(8,432
|
)
|
(6,057
|
)
|
||||
Other liabilities
|
(6,175
|
)
|
(8,653
|
)
|
||||
Net cash provided by operating activities
|
13,454
|
4,436
|
||||||
|
||||||||
INVESTING ACTIVITIES
|
||||||||
Purchase of property and equipment
|
(461
|
)
|
(1,044
|
)
|
||||
Capitalization of internally developed software costs
|
(362
|
)
|
(662
|
)
|
||||
Purchase of businesses, net of cash acquired
|
(7,144
|
)
|
(277
|
)
|
||||
Net cash used in investing activities
|
(7,967
|
)
|
(1,983
|
)
|
||||
|
||||||||
FINANCING ACTIVITIES
|
||||||||
Proceeds from line of credit
|
66,000
|
59,000
|
||||||
Payments on line of credit
|
(59,500
|
)
|
(59,000
|
)
|
||||
Payment of contingent consideration for purchase of business
|
(978
|
)
|
-
|
|||||
Proceeds from the sales of stock through the Employee Stock Purchase Plan
|
47
|
53
|
||||||
Purchases of treasury stock
|
(8,122
|
)
|
-
|
|||||
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting
|
(2,295
|
)
|
(2,351
|
)
|
||||
Net cash used in financing activities
|
(4,848
|
)
|
(2,298
|
)
|
||||
Effect of exchange rate on cash and cash equivalents
|
135
|
50
|
||||||
Change in cash and cash equivalents
|
774
|
205
|
||||||
Cash and cash equivalents at beginning of period
|
10,113
|
8,811
|
||||||
Cash and cash equivalents at end of period
|
$
|
10,887
|
$
|
9,016
|
||||
|
||||||||
Supplemental disclosures:
|
||||||||
Cash paid for income taxes
|
$
|
237
|
$
|
593
|
||||
Cash paid for interest
|
$
|
235
|
$
|
373
|
||||
|
||||||||
Non-cash activity:
|
||||||||
Stock issued for purchase of business
|
$
|
2,286
|
$
|
-
|
|
Shares
|
Weighted-Average
Grant Date Fair Value
|
||||||
Restricted stock awards outstanding at December 31, 2016
|
1,403
|
$
|
17.52
|
|||||
Awards granted
|
364
|
18.36
|
||||||
Awards vested
|
(292
|
)
|
20.13
|
|||||
Awards forfeited
|
(40
|
)
|
15.49
|
|||||
Restricted stock awards outstanding at March 31, 2017
|
1,435
|
$
|
17.27
|
Three Months Ended
|
||||||||
|
March 31,
|
|||||||
|
2017
|
2016
|
||||||
Net income
|
$
|
2,709
|
$
|
5,406
|
||||
Basic:
|
||||||||
Weighted-average shares of common stock outstanding
|
33,383
|
33,911
|
||||||
Shares used in computing basic net income per share
|
33,383
|
33,911
|
||||||
Effect of dilutive securities:
|
||||||||
Restricted stock subject to vesting
|
402
|
363
|
||||||
Contingently issuable shares (1)
|
-
|
7
|
||||||
Shares issuable for acquisition consideration (2)
|
509
|
561
|
||||||
Shares used in computing diluted net income per share
|
34,294
|
34,842
|
||||||
|
||||||||
Basic net income per share
|
$
|
0.08
|
$
|
0.16
|
||||
Diluted net income per share
|
$
|
0.08
|
$
|
0.16
|
||||
|
||||||||
Anti-dilutive restricted stock not included in the calculation of diluted net income per share
|
122
|
112
|
(1) |
For the three months ended March 31, 2016, this represents the Company’s estimate of shares to be issued to Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”) pursuant to the Asset Purchase Agreement.
|
(2) |
For the three months ended March 31, 2017, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with BioPharm Systems, Inc. (“BioPharm”); (ii) the Asset Purchase Agreement with Zeon; (iii) the Asset Purchase Agreement with The Pup Group, Inc. d/b/a Enlighten (“Enlighten”); and (iv) the Asset Purchase Agreement with RAS & Associates, LLC (“RAS”) as part of the consideration. For the three months ended March 31, 2016, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with BioPharm; (ii) the Asset Purchase Agreement with Zeon; (iii) the Stock Purchase Agreement for Market Street Solutions, Inc. (“Market Street”); and (iv) the Asset Purchase Agreement with Enlighten as part of the consideration.
|
|
Operating
Leases
|
|||
2017 remaining
|
$
|
4,589
|
||
2018
|
5,206
|
|||
2019
|
4,684
|
|||
2020
|
4,335
|
|||
2021
|
2,696
|
|||
Thereafter
|
1,558
|
|||
Total minimum lease payments
|
$
|
23,068
|
|
|
March 31, 2017 |
|
December 31, 2016 | ||||
|
(in thousands)
|
|||||||
Accounts receivable:
|
||||||||
Accounts receivable
|
$
|
55,015
|
$
|
80,461
|
||||
Unbilled revenues
|
33,669
|
24,518
|
||||||
Allowance for doubtful accounts
|
(1,034
|
)
|
(1,277
|
)
|
||||
Total
|
$
|
87,650
|
$
|
103,702
|
Property and equipment:
|
||||||||
Computer hardware (useful life of 3 years)
|
$
|
12,392
|
$
|
12,191
|
||||
Furniture and fixtures (useful life of 5 years)
|
3,325
|
3,306
|
||||||
Leasehold improvements (useful life of 5 years)
|
1,967
|
1,958
|
||||||
Software (useful life of 1 to 7 years)
|
9,469
|
9,186
|
||||||
Less: Accumulated depreciation
|
(19,016
|
)
|
(17,753
|
)
|
||||
Total
|
$
|
8,137
|
$
|
8,888
|
Other current liabilities:
|
||||||||
Accrued variable compensation
|
$
|
6,091
|
$
|
10,979
|
||||
Deferred revenue
|
3,179
|
3,138
|
||||||
Payroll related costs
|
2,665
|
2,607
|
||||||
Accrued subcontractor fees
|
505
|
1,049
|
||||||
Accrued medical claims expense
|
1,880
|
1,859
|
||||||
Professional fees
|
424
|
420
|
||||||
Estimated fair value of contingent consideration liability (1)
|
4,087
|
3,384
|
||||||
Net working capital settlements
|
130
|
62
|
||||||
Other current liabilities
|
3,995
|
4,139
|
||||||
Total
|
$
|
22,956
|
$
|
27,637
|
Other non-current liabilities:
|
||||||||
Deferred compensation liability
|
$
|
3,990
|
$
|
3,662
|
||||
Deferred income taxes
|
14,220
|
12,853
|
||||||
Other non-current liabilities
|
2,625
|
2,543
|
||||||
Total
|
$
|
20,835
|
$
|
19,058
|
(1) |
As of March 31, 2017, represents the fair value estimate of additional earnings-based contingent consideration that may be realized by Enlighten, Bluetube, LLC (“Bluetube”) and RAS twelve months after the applicable acquisition. As of December 31, 2016, represents the fair value estimate of additional earnings-based contingent consideration that may be realized by the Market Street selling shareholders, Enlighten and Bluetube twelve months after the applicable acquisition.
|
Acquired tangible assets
|
$
|
0.9
|
||
Acquired intangible assets
|
3.1
|
|||
Liabilities assumed
|
(0.6
|
)
|
||
Goodwill
|
5.7
|
|||
Total purchase price
|
$
|
9.1
|
Weighted Average Useful Life
|
Useful Life
|
Aggregate Acquisitions
|
||||
Customer relationships
|
5 years
|
5 years
|
$
|
2.5
|
||
Customer backlog
|
6 months
|
6 months
|
0.4
|
|||
Non-compete agreements
|
5 years
|
5 years
|
0.2
|
|||
Trade name
|
1 year
|
1 year
|
-
|
|||
Total acquired intangible assets
|
|
|
$
|
3.1
|
Acquired tangible assets
|
$
|
0.9
|
||
Acquired intangible assets
|
4.9
|
|||
Liabilities assumed
|
(1.0
|
)
|
||
Goodwill
|
5.8
|
|||
Total purchase price
|
$
|
10.6
|
Weighted Average Useful Life
|
Useful Life
|
Aggregate Acquisitions
|
||||
Customer relationships
|
6 years
|
6 years
|
$
|
4.5
|
||
Customer backlog
|
3 months
|
3 months
|
0.2
|
|||
Non-compete agreements
|
4 years
|
2 - 5 years
|
0.2
|
|||
Trade name
|
1 year
|
1 year
|
-
|
|||
Total acquired intangible assets
|
|
|
$
|
4.9
|
|
Acquisition Date to | |||
|
March 31, 2017 | |||
Revenues
|
$
|
2,899
|
||
Net income
|
$
|
227
|
Three Months Ended March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenues
|
$
|
111,019
|
$
|
127,397
|
||||
Net income
|
$
|
3,268
|
$
|
5,106
|
||||
Basic net income per share
|
$
|
0.10
|
$
|
0.15
|
||||
Diluted net income per share
|
$
|
0.10
|
$
|
0.15
|
||||
Shares used in computing basic net income per share
|
33,385
|
33,971
|
||||||
Shares used in computing diluted net income per share
|
34,299
|
34,989
|
Balance at December 31, 2016
|
$
|
275,205
|
||
Preliminary purchase price allocations for acquisitions
|
5,836
|
|||
Effect of foreign currency translation adjustments
|
200
|
|||
Balance at March 31, 2017
|
$
|
281,241
|
|
March 31, 2017
|
December 31, 2016
|
||||||||||||||||||||||
|
Gross
Carrying
Amounts
|
Accumulated
Amortization
|
Net
Carrying
Amounts
|
Gross
Carrying
Amounts
|
Accumulated
Amortization
|
Net
Carrying
Amounts
|
||||||||||||||||||
Customer relationships
|
$
|
66,688
|
$
|
(27,663
|
)
|
$
|
39,025
|
$
|
67,648
|
$
|
(30,458
|
)
|
$
|
37,190
|
||||||||||
Non-compete agreements
|
1,247
|
(601
|
)
|
646
|
1,018
|
(557
|
)
|
461
|
||||||||||||||||
Customer backlog
|
-
|
-
|
-
|
390
|
(195
|
)
|
195
|
|||||||||||||||||
Trade name
|
60
|
(22
|
)
|
38
|
30
|
(7
|
)
|
23
|
||||||||||||||||
Internally developed software
|
11,367
|
(4,312
|
)
|
7,055
|
11,342
|
(4,096
|
)
|
7,246
|
||||||||||||||||
Total
|
$
|
79,362
|
$
|
(32,598
|
)
|
$
|
46,764
|
$
|
80,428
|
$
|
(35,313
|
)
|
$
|
45,115
|
Customer relationships
|
5 – 10 years
|
Non-compete agreements
|
2 – 5 years
|
Internally developed software
|
1 – 7 years
|
Trade name
|
1 year
|
Customer backlog
|
6 months
|
2017 remaining
|
$
|
9,124
|
||
2018
|
$
|
11,106
|
||
2019
|
$
|
9,990
|
||
2020
|
$
|
6,903
|
||
2021
|
$
|
4,861
|
||
Thereafter
|
$
|
4,780
|
|
March 31, 2017
|
December 31, 2016
|
||||||
Derivatives not designated as hedges
|
||||||||
Foreign exchange contracts
|
$
|
3,574
|
$
|
4,541
|
||||
Total derivatives not designated as hedges
|
$
|
3,574
|
$
|
4,541
|
Financial Results
(in thousands)
|
Explanation for Increases (Decreases) Over Prior Year Period
(in thousands)
|
|||||||||||||||||||
|
Three Months Ended March 31,
|
|
Total Decrease Over Prior Year Period
|
|
Increase Attributable to Acquired Companies |
|
Decrease Attributable to Base Business | |||||||||||||
2017
|
2016
|
|||||||||||||||||||
Services revenues
|
$
|
100,888
|
$
|
109,747
|
$
|
(8,859
|
)
|
$
|
5,155
|
$
|
(14,014
|
)
|
||||||||
Software and hardware revenues
|
6,998
|
9,476
|
(2,478
|
)
|
-
|
(2,478
|
)
|
|||||||||||||
Reimbursable expenses
|
3,133
|
4,620
|
(1,487
|
)
|
81
|
(1,568
|
)
|
|||||||||||||
Total revenues
|
$
|
111,019
|
$
|
123,843
|
$
|
(12,824
|
)
|
$
|
5,236
|
$
|
(18,060
|
)
|
|
As of
|
|
As of | |||||
|
|
March 31, 2017
|
|
December 31, 2016 | ||||
Cash, cash equivalents and investments (1)
|
$
|
10.9
|
$
|
10.1
|
||||
Working capital (including cash and cash equivalents) (2)
|
$
|
76.2
|
$
|
76.4
|
||||
Amounts available under credit facilities
|
$
|
86.5
|
$
|
93.0
|
Period
|
Total Number of
Shares Purchased
|
Average Price
Paid Per Share (1)
|
Total Number of Shares
Purchased as Part of Publicly
Announced Plans or Programs
|
Approximate Dollar Value
of Shares that May Yet
Be Purchased Under
the Plans or Programs
|
||||||||||||
Beginning balance as of December 31, 2016
|
10,553,624
|
$
|
9.70
|
10,553,624
|
$
|
7,619,184
|
||||||||||
January 1-31, 2017
|
107,500
|
17.75
|
107,500
|
$
|
5,711,558
|
|||||||||||
February 1-28, 2017
|
66,000
|
17.98
|
66,000
|
$
|
29,524,715
|
|||||||||||
March 1-31, 2017
|
279,649
|
17.98
|
279,649
|
$
|
24,496,732
|
|||||||||||
Ending balance as of March 31, 2017
|
11,006,773
|
$
|
10.04
|
11,006,773
|
(1) |
Average price paid per share includes commission.
|
|
PERFICIENT, INC.
|
|
|
|
|
Date: May 4, 2017
|
By:
|
/s/ Jeffrey S. Davis
|
|
Jeffrey S. Davis
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
Date: May 4, 2017
|
By:
|
/s/ Paul E. Martin
|
|
Paul E. Martin
|
|
|
Chief Financial Officer
(Principal Financial Officer)
|
1 Year Perficient Chart |
1 Month Perficient Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions